Literature DB >> 12444928

The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.

Patrik Wollberg1, Johan Lennartsson, Eva Gottfridsson, Akihiko Yoshimura, Lars Rönnstrand.   

Abstract

The adapter protein APS has previously been shown to be involved in recruiting the ubiquitin E3 ligase c-Cbl to the insulin receptor, the platelet-derived growth factor beta-receptor and the erythropoietin receptor, leading to increased degradation of the receptors and inhibition of mitogenesis. Here we demonstrate, by use of immobilized synthetic phosphopeptides corresponding to various autophosphorylated tyrosine residues in the receptor for stem-cell factor (c-Kit), that APS preferentially associates with phosphorylated Tyr-568 and Tyr-936. Tyr-568 has previously been identified as the binding site of the Src family of tyrosine kinases, the Csk-homologous kinase CHK, and the protein tyrosine phosphatase SHP-2. We have recently demonstrated that Tyr-936 is an autophosphorylation site involved in binding the adapter proteins Grb2 and Grb7. We could further demonstrate that the critical determinant for binding of APS is the presence of either a leucine or an isoleucine residue in the position +3 to the phosphorylated tyrosine. This allowed us to design mutants that selectively failed to associate with APS, while still associating with Src family members, SHP-2 and Grb2, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12444928      PMCID: PMC1223215          DOI: 10.1042/BJ20020716

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells.

Authors:  D Linnekin; C S DeBerry; S Mou
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

2.  Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site.

Authors:  R Herbst; S Munemitsu; A Ullrich
Journal:  Oncogene       Date:  1995-01-19       Impact factor: 9.867

3.  Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes.

Authors:  D J Price; B Rivnay; Y Fu; S Jiang; S Avraham; H Avraham
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

4.  SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.

Authors:  M Kozlowski; L Larose; F Lee; D M Le; R Rottapel; K A Siminovitch
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

5.  Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation.

Authors:  M Yokouchi; R Suzuki; M Masuhara; S Komiya; A Inoue; A Yoshimura
Journal:  Oncogene       Date:  1997-07-03       Impact factor: 9.867

6.  APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.

Authors:  M Yokouchi; T Wakioka; H Sakamoto; H Yasukawa; S Ohtsuka; A Sasaki; M Ohtsubo; M Valius; A Inoue; S Komiya; A Yoshimura
Journal:  Oncogene       Date:  1999-01-21       Impact factor: 9.867

7.  Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells.

Authors:  H Serve; Y C Hsu; P Besmer
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

8.  Identification and characterization of novel substrates of Trk receptors in developing neurons.

Authors:  X Qian; A Riccio; Y Zhang; D D Ginty
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

9.  The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha.

Authors:  S Miyake; M L Lupher; B Druker; H Band
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

10.  The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells.

Authors:  H Odai; K Sasaki; A Iwamatsu; Y Hanazono; T Tanaka; K Mitani; Y Yazaki; H Hirai
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

View more
  12 in total

1.  The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction.

Authors:  Jianmin Sun; Malin Pedersen; Lars Rönnstrand
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

Review 2.  SH2B1 regulation of energy balance, body weight, and glucose metabolism.

Authors:  Liangyou Rui
Journal:  World J Diabetes       Date:  2014-08-15

3.  Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.

Authors:  Kristina Masson; Elke Heiss; Hamid Band; Lars Rönnstrand
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

4.  Identifying three-dimensional structures of autophosphorylation complexes in crystals of protein kinases.

Authors:  Qifang Xu; Kimberly L Malecka; Lauren Fink; E Joseph Jordan; Erin Duffy; Samuel Kolander; Jeffrey R Peterson; Roland L Dunbrack
Journal:  Sci Signal       Date:  2015-12-01       Impact factor: 8.192

5.  Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.

Authors:  Sigal Gery; Qi Cao; Saskia Gueller; Hongtao Xing; Ayalew Tefferi; H Phillip Koeffler
Journal:  J Leukoc Biol       Date:  2009-03-17       Impact factor: 4.962

Review 6.  A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Authors:  Zhi-Chao Feng; Matthew Riopel; Alex Popell; Rennian Wang
Journal:  Diabetologia       Date:  2015-02-03       Impact factor: 10.122

7.  A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis.

Authors:  Valter Agosti; Vinit Karur; Pradeep Sathyanarayana; Peter Besmer; Don M Wojchowski
Journal:  Exp Hematol       Date:  2008-12-18       Impact factor: 3.084

8.  Beginning of personalized medicine in Panama: Molecular and pathological characteristics of gastrointestinal stromal tumors from archival paraffin-embedded tissue.

Authors:  Yaxelis Mendoza; Carlos Singh; Juan Castillo Mewa; Evelise Fonseca; Rebecca Smith; Juan M Pascale
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

9.  Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples.

Authors:  Jean-Baptiste Bachet; Séverine Tabone-Eglinger; Sophie Dessaux; Anthony Besse; Sabrina Brahimi-Adouane; Jean-François Emile; Jean-Yves Blay; Laurent Alberti
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

10.  Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development.

Authors:  Valter Agosti; Selim Corbacioglu; Imke Ehlers; Claudia Waskow; Gunhild Sommer; Georgina Berrozpe; Holger Kissel; Christine M Tucker; Katia Manova; Malcolm A S Moore; Hans-Reimer Rodewald; Peter Besmer
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.